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ABSTRACT 
          Tumor growth and metastasis are key processes in understanding tumor progression and 
cancer fatality. Pyruvate Kinase type M2 (PKM2) is a key enzyme that regulates glucose 
metabolism in cells in a biochemical pathway known as glycolysis. Glycolysis provides cells 
with energy (ATP) and building blocks (nucleic acids, amino acids and lipids) that are critical for 
cell survival and proliferation. Therefore, cancer cells rely heavily on this metabolic process to 
survive and thrive. PKM2 is overexpressed in most cancers, and is highly involved with cancer 
cell growth. Several recent studies have further revealed a potential role of PKM2 in regulating 
epithelial-mesenchymal transition (EMT[PTT1]) and cancer cell metastasis. The aim of this 
study is to study the mechanisms by which PKM2 regulates EMT and promotes cancer 
metastasis. 
          In our previous studies, we identified a potential Pkm2 protein interacting partner - Twist1 
protein. Twist1 is a key transcription factor that regulates EMT and cancer metastasis. It has 
been reported that the nuclear translocation of PKM2 can regulate transcriptional activity of 
several other transcription factors. Therefore, the interaction between Pkm2 and Twist1 can 
potentially enhance Twist1 transcriptional activity in EMT and metastasis. 
         In the current study, we are knocking out the PKM2 gene in cancer and immortalized 
primary cell lines by using the CRISPR-Cas9 system. We will study the changes in cell 
proliferation and migration after knocking out PKM2. Later, we will overexpress TWIST1 in 
these cells by using plasmid transfection or viral infection and study whether TWIST1 can 
restore the cells to their original phenotype. 
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